Gestalt Diagnostics

Gestalt Diagnostics develops and provides PathFlow, an AI-powered digital pathology platform used by healthcare organizations, medical centers, and research institutions. PathFlow integrates with existing lab systems to improve diagnostic speed and accuracy, offering better access to expert consultation and research. Its AI capabilities enable biomarker scoring for optimized patient-therapy matching and data analysis for disease progression studies.

Funding Round: Series A

Funding Amount: $7.5M

Date: 28-Apr-2025

Investors: Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds, prominent angel investors from the Pacific Northwest

Markets: Healthtech, AI, Pathology

HQ: Spokane, Washington, United States

Founded: 2017

Website: https://www.gestaltdiagnostics.com/

LinkedIn: https://www.linkedin.com/company/gestalt-diagnostics

Twitter: https://twitter.com/Gestalt122

Instagram:

Facebook: https://www.facebook.com/Gestaltdiagnostics